Can People Achieve a Target Omega-3 Index by Following a Personalized Omega-3 Dosing Regimen?

The goal of this project is to evaluate the efficacy of personalized dosage recommendations of Parasol Omega-3 Fish Oil on achieving an Omega-3 Index of >8% in individuals with a baseline Omega-3 Index <8% over a 90-day period.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Omega-3 Fatty Acids

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Baseline omega-3 index less than 8%

Exclusion criteria

Currently taking a fish oil or other omega-3 supplement

Treatment and study plan

Fish oil supplementation

Dietary Supplement

Enrolled participants will be instructed to start taking 2 capsules per day on the day they take their baseline O3I and once O3I results are available to adjust to a personalized dose of Fish Oil, based on their baseline Omega-3 Index, and instructed to continue their current omega-3 dietary intake. Recommendations will be:

O3I > 6.8% but ≤ 8% - 1 capsule
O3I > 5.5% but ≤ 6.8% - 2 capsules
O3I > 4.4% but ≤ 5.5% - 3 capsules
O3I ≤ 4.4% - 4 capsules

Primary outcomes

Omega-3 index

Time frame: 90 days

RBC omega-3 index value

Study contacts

Contact information is provided by the study sponsor or research team.

William Harris, Ph.D.

CONTACT

[email protected]

913-302-9433

Sponsors and collaborators

Lead sponsor

Fatty Acid Research Institute

Other

Collaborators

Omegaquant Analytics, LLC

Registry information

Official study title

Effects of Using Personalized Dosage Recommendations of Parasol Omega-3 Fish Oil Based on Omega-3 Index Values: A Pilot Study

Important dates

Study start: 2026
Primary completion: 2026
Study completion: 2026
First posted: Mar 18, 2026
Registry last updated: Mar 18, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Enrolling by Invitation